Shopping Cart 0
Cart Subtotal
USD 0

Navidea Biopharmaceuticals Inc (NAVB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Navidea Biopharmaceuticals Inc (Navidea) is a biopharmaceutical company that develops precision immunodiagnostic agents and immunotherapeutics.. The company is focused on developing multiple precision-targeted products based on its Manocept platform to improve patient care. Its pipeline products include MT-1002; MT-2002; Tc99m tilmanocept for Kaposi's, NAS, Cardiovascular diseases, Sentinal Node Biopsy, and Solid tumors lymphatic mapping and NAV4694 for Alzhemier's Disease. Navidea by utilizing its Manocept platform develops multiple precision-targeted products to identify pathways of undetected disease and provide better diagnostic accuracy, clinical decision-making and effective treatment. The company has presence in the US, and the UK. Navidea is headquartered in Dublin, Ohio, the US.

Navidea Biopharmaceuticals Inc (NAVB)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Navidea Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Navidea Raises USD50 Million in Venture Financing 11

Partnerships 12

BIND Therapeutics Enters into Research Agreement with Macrophage Therapeutics 12

Hainan Sinotau Enters into Co-Development Agreement with Navidea for Lymphoseek 13

Navidea Biopharm forms Joint Venture with Rheumco 14

Navidea Biopharma Amends Agreement with University of California San Francisco 15

Licensing Agreements 16

Navidea Enters into License Agreement with Norgine for Lymphoseek 16

Equity Offering 17

Navidea Biopharma Raises USD3 Million in Private Placement of Shares 17

Navidea Biopharma Plans to Raise up to USD100 in Public Offering of Shares 18

Macrophage Therapeutics Raises USD0.5 Million in First Tranche of Private Placement 19

Asset Transactions 20

Cardinal Health Acquires Lymphoseek from Navidea Biopharma 20

Navidea Biopharmaceuticals Inc-Key Competitors 22

Navidea Biopharmaceuticals Inc-Key Employees 23

Navidea Biopharmaceuticals Inc-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Financial Announcements 25

Aug 08, 2018: Navidea Biopharmaceuticals reports second quarter 2018 financial results 25

May 08, 2018: Navidea Biopharmaceuticals Announces First Quarter 2018 Financial Results 26

Mar 08, 2018: Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results 27

Nov 08, 2017: Navidea Biopharmaceuticals Reports Third Quarter 2017 Financial Results 29

Aug 08, 2017: Navidea Biopharmaceuticals Reports Second Quarter 2017 Financial Results 31

May 09, 2017: Navidea Biopharmaceuticals Reports First Quarter 2017 Financial Results 32

Mar 29, 2017: Navidea Provides Corporate Update and Reports Full Year 2016 Results 34

Corporate Communications 37

Aug 15, 2018: Navidea Biopharmaceuticals receives noncompliance notice from NYSE American 37

Other Significant Developments 38

Sep 17, 2018: Navidea Biopharmaceuticals announces acceptance into the National Institutes of Health commercialization accelerator program 38

Aug 16, 2018: Navidea Biopharmaceuticals announces details of 2018 Annual General Meeting 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Navidea Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Navidea Biopharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Navidea Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Navidea Raises USD50 Million in Venture Financing 11

BIND Therapeutics Enters into Research Agreement with Macrophage Therapeutics 12

Hainan Sinotau Enters into Co-Development Agreement with Navidea for Lymphoseek 13

Navidea Biopharm forms Joint Venture with Rheumco 14

Navidea Biopharma Amends Agreement with University of California San Francisco 15

Navidea Enters into License Agreement with Norgine for Lymphoseek 16

Navidea Biopharma Raises USD3 Million in Private Placement of Shares 17

Navidea Biopharma Plans to Raise up to USD100 in Public Offering of Shares 18

Macrophage Therapeutics Raises USD0.5 Million in First Tranche of Private Placement 19

Cardinal Health Acquires Lymphoseek from Navidea Biopharma 20

Navidea Biopharmaceuticals Inc, Key Competitors 22

Navidea Biopharmaceuticals Inc, Key Employees 23

Navidea Biopharmaceuticals Inc, Subsidiaries 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Navidea Biopharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Navidea Biopharmaceuticals Inc (Navidea) is a biopharmaceutical company that develops precision immunodiagnostic agents and immunotherapeutics.. The company is focused on developing multiple precision-targeted products based on its Manocept platform to improve patient care. Its pipeline products include MT-1002; MT-2002; Tc99m tilmanocept for Kaposi's, NAS, Cardiovascular diseases, Sentinal Node Biopsy, and Solid tumors lymphatic mapping and NAV4694 for Alzhemier's Disease. Navidea by utilizing its Manocept platform develops multiple precision-targeted products to identify pathways of undetected disease and provide better diagnostic accuracy, clinical decision-making and effective treatment. The company has presence in the US, and the UK. Navidea is headquartered in Dublin, Ohio, the US.

Navidea Biopharmaceuticals Inc (NAVB)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Navidea Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Navidea Raises USD50 Million in Venture Financing 11

Partnerships 12

BIND Therapeutics Enters into Research Agreement with Macrophage Therapeutics 12

Hainan Sinotau Enters into Co-Development Agreement with Navidea for Lymphoseek 13

Navidea Biopharm forms Joint Venture with Rheumco 14

Navidea Biopharma Amends Agreement with University of California San Francisco 15

Licensing Agreements 16

Navidea Enters into License Agreement with Norgine for Lymphoseek 16

Equity Offering 17

Navidea Biopharma Raises USD3 Million in Private Placement of Shares 17

Navidea Biopharma Plans to Raise up to USD100 in Public Offering of Shares 18

Macrophage Therapeutics Raises USD0.5 Million in First Tranche of Private Placement 19

Asset Transactions 20

Cardinal Health Acquires Lymphoseek from Navidea Biopharma 20

Navidea Biopharmaceuticals Inc-Key Competitors 22

Navidea Biopharmaceuticals Inc-Key Employees 23

Navidea Biopharmaceuticals Inc-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Financial Announcements 25

Aug 08, 2018: Navidea Biopharmaceuticals reports second quarter 2018 financial results 25

May 08, 2018: Navidea Biopharmaceuticals Announces First Quarter 2018 Financial Results 26

Mar 08, 2018: Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results 27

Nov 08, 2017: Navidea Biopharmaceuticals Reports Third Quarter 2017 Financial Results 29

Aug 08, 2017: Navidea Biopharmaceuticals Reports Second Quarter 2017 Financial Results 31

May 09, 2017: Navidea Biopharmaceuticals Reports First Quarter 2017 Financial Results 32

Mar 29, 2017: Navidea Provides Corporate Update and Reports Full Year 2016 Results 34

Corporate Communications 37

Aug 15, 2018: Navidea Biopharmaceuticals receives noncompliance notice from NYSE American 37

Other Significant Developments 38

Sep 17, 2018: Navidea Biopharmaceuticals announces acceptance into the National Institutes of Health commercialization accelerator program 38

Aug 16, 2018: Navidea Biopharmaceuticals announces details of 2018 Annual General Meeting 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Navidea Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Navidea Biopharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Navidea Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Navidea Raises USD50 Million in Venture Financing 11

BIND Therapeutics Enters into Research Agreement with Macrophage Therapeutics 12

Hainan Sinotau Enters into Co-Development Agreement with Navidea for Lymphoseek 13

Navidea Biopharm forms Joint Venture with Rheumco 14

Navidea Biopharma Amends Agreement with University of California San Francisco 15

Navidea Enters into License Agreement with Norgine for Lymphoseek 16

Navidea Biopharma Raises USD3 Million in Private Placement of Shares 17

Navidea Biopharma Plans to Raise up to USD100 in Public Offering of Shares 18

Macrophage Therapeutics Raises USD0.5 Million in First Tranche of Private Placement 19

Cardinal Health Acquires Lymphoseek from Navidea Biopharma 20

Navidea Biopharmaceuticals Inc, Key Competitors 22

Navidea Biopharmaceuticals Inc, Key Employees 23

Navidea Biopharmaceuticals Inc, Subsidiaries 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Navidea Biopharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.